Biomarkers currently play an important role in the detection and management of patients
with several different types of gastrointestinal cancer, especially colorectal, gastric, gastro …

Gastric cancer (GC) is the third leading cause of cancer mortality worldwide. Although
surgical resection is a potentially curative approach for localized cases of GC, most cases of …

Gastric cancer is among the leading causes of cancer related death worldwide. Patients with
gastric cancer are typically asymptomatic, and diagnosed at late stages, supporting the need …

Chondroitin polymerizing factor (CHPF) is an important glycosyltransferase involved in the
biosynthesis of chondroitin sulfate. However, the relationship between CHPF and gastric …

Gastric cancer is one of the most frequent and lethal malignancies worldwide because of
high frequency of metastasis. Tumor cell motility and invasion play fundamental roles in …

Background Gastric cancer is currently the fourth leading cause of cancer-related death
worldwide. Gastric cancer is often diagnosed at advanced stages and the outcome of the …

The human epidermal growth factor receptor-2 (HER2/neu/ERBB2) is overexpressed in
several cancer types. Although therapies targeting the HER2/neu protein result in inhibition …

Genetic alterations are the starting point leading to numerous changes in clinical and
pathologic features (phenotypes) of individual cancers; however, their inter‐relationships in …

Aberrant activation of the HGF/MET signaling axis has been strongly implicated in the
malignant transformation and progression of gastroesophageal cancer (GEC). MET receptor …

Background We investigated the expression of two α v integrins, α v β 3 and α v β 5, in
gastric cancer (GC) by testing the following hypotheses: that these molecules are expressed …